Indications
Dasvir is used together with sofosbuvir to treat long-term (chronic) hepatitis C virus (HCV) infection in adults.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Daclatasvir is a direct-acting antiviral (DAA) that works against the Hepatitis C Virus (HCV). It blocks NS5A, a nonstructural protein the virus needs to function, by attaching to the N-terminus of this protein. Through this action, Daclatasvir stops the virus from replicating its RNA and from assembling new virus particles.
Studies of Daclatasvir-resistant viruses, along with biochemical research and computer modeling, show that Daclatasvir specifically targets the N-terminus within Domain 1 of NS5A. This interaction appears to distort the protein's structure enough to disrupt its normal functions.
Pregnancy & Breastfeeding
Pregnancy: There isn't enough data on Daclatasvir use in pregnant women to know what risk, if any, it may pose.
Breastfeeding: It isn't known whether Daclatasvir passes into human breast milk, or whether it could affect a breastfed baby or milk supply.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.